SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review

被引:92
作者
Fathizadeh, Hadis [1 ]
Afshar, Saman [2 ]
Masoudi, Mahmood Reza [3 ]
Gholizadeh, Pourya [4 ]
Asgharzadeh, Mohammad [5 ]
Ganbarov, Khudaverdi [6 ]
Kose, Sukran [7 ]
Yousefi, Mehdi [8 ]
Kafil, Hossein Samadi [9 ]
机构
[1] Sirjan Sch Med Sci, Dept Lab Sci, Sirjan, Iran
[2] Univ Tabriz, Fac Nat Sci, Dept Anim Biol, Tabriz, Iran
[3] Sirjan Sch Med Sci, Dept Internal Med, Sirjan, Iran
[4] Tabriz Univ Med Sci, Res Ctr Pharmaceut Nanotechnol, Tabriz, Iran
[5] Tabriz Univ Med Sci, Biotechnol Res Ctr, Tabriz, Iran
[6] Baku State Univ, Dept Microbiol, Baku, Azerbaijan
[7] Univ Hlth Sci, Tepecik Training & Res Hosp, Dept Infect Dis & Clin Microbiol, Izmir, Turkey
[8] Tabriz Univ Med Sci, Stem Cell Res Ctr, Tabriz, Iran
[9] Tabriz Univ Med Sci, Fac Med, Drug Appl Res Ctr, Tabriz, Iran
关键词
Covid-19; Sars-Cov-2; Vaccine; Infection; Adenovirus; Inactivated; Effectiveness; ACUTE RESPIRATORY SYNDROME; ADENOVIRUS TYPE 5; SARS CORONAVIRUS; IMMUNE-RESPONSES; SPIKE PROTEIN; DNA VACCINES; INFECTION; VIRUS; ANTIBODIES; MICE;
D O I
10.1016/j.ijbiomac.2021.08.076
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The world has been suffering from COVID-19 disease for more than a year, and it still has a high mortality rate. In addition to the need to minimize transmission of the virus through non-pharmacological measures such as the use of masks and social distance, many efforts are being made to develop a variety of vaccines to prevent the disease worldwide. So far, several vaccines have reached the final stages of safety and efficacy in various phases of clinical trials, and some, such as Moderna/NIAID and BioNTech/Pfizer, have reported very high safety and protection. The important point is that comparing different vaccines is not easy because there is no set standard for measuring neutralization. In this study, we have reviewed the common platforms of COVID-19 vaccines and tried to present the latest reports on the effectiveness of these vaccines.
引用
收藏
页码:740 / 750
页数:11
相关论文
共 149 条
[1]   mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials [J].
A Feldman, Robert ;
Fuhr, Rainard ;
Smolenov, Igor ;
Ribeiro, Amilcar ;
Panther, Lori ;
Watson, Mike ;
Senn, Joseph J. ;
Smith, Mike ;
Almarsson, Orn ;
Pujar, Hari S. ;
Laska, Michael E. ;
Thompson, James ;
Zaks, Tal ;
Ciaramella, Giuseppe .
VACCINE, 2019, 37 (25) :3326-3334
[2]   Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2)-an update on the status [J].
Abd El-Aziz, Tarek Mohamed ;
Stockand, James D. .
INFECTION GENETICS AND EVOLUTION, 2020, 83
[3]   Adenovirus type 5 with modified hexons induces robust transgene-specific immune responses in mice with pre-existing immunity against adenovirus type 5 [J].
Abe, Shinya ;
Okuda, Kenji ;
Ura, Takehiro ;
Kondo, Asami ;
Yoshida, Atsushi ;
Yoshizaki, Shinji ;
Mizuguchi, Hiroyuki ;
Klinman, Dennis ;
Shimada, Masaru .
JOURNAL OF GENE MEDICINE, 2009, 11 (07) :570-579
[4]   Efficacy of an Adjuvanted Middle East Respiratory Syndrome Coronavirus Spike Protein Vaccine in Dromedary Camels and Alpacas [J].
Adney, Danielle R. ;
Wang, Lingshu ;
van Doremalen, Neeltje ;
Shi, Wei ;
Zhang, Yi ;
Kong, Wing-Pui ;
Miller, Megan R. ;
Bushmaker, Trenton ;
Scott, Dana ;
de Wit, Emmie ;
Modjarrad, Kayvon ;
Petrovsky, Nikolai ;
Graham, Barney S. ;
Bowen, Richard A. ;
Munster, Vincent J. .
VIRUSES-BASEL, 2019, 11 (03)
[5]   COVID-19 reinfection in a healthcare worker after exposure with high dose of virus: A case report [J].
Ahmadian, Shahram ;
Fathizadeh, Hadis ;
Shabestari Khiabani, Saeid ;
Asgharzadeh, Mohammad ;
Kafil, Hossein Samadi .
CLINICAL CASE REPORTS, 2021, 9 (06)
[6]   Long-term efficacy and safety of mRNA therapy in two murine models of methylmalonic acidemia [J].
An, Ding ;
Frassetto, Andrea ;
Jacquinet, Eric ;
Eybye, Marianne ;
Milano, Joseph ;
DeAntonis, Christine ;
Vi Nguyen ;
Laureano, Rodrigo ;
Milton, Jaclyn ;
Sabnis, Staci ;
Lukacs, Christine M. ;
Guey, Lin T. .
EBIOMEDICINE, 2019, 45 :519-528
[7]   The proximal origin of SARS-CoV-2 [J].
Andersen, Kristian G. ;
Rambaut, Andrew ;
Lipkin, W. Ian ;
Holmes, Edward C. ;
Garry, Robert F. .
NATURE MEDICINE, 2020, 26 (04) :450-452
[8]   Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults [J].
Anderson, E. J. ;
Rouphael, N. G. ;
Widge, A. T. ;
Jackson, L. A. ;
Roberts, P. C. ;
Makhene, M. ;
Chappell, J. D. ;
Denison, M. R. ;
Stevens, L. J. ;
Pruijssers, A. J. ;
McDermott, A. B. ;
Flach, B. ;
Lin, B. C. ;
Doria-Rose, N. A. ;
O'Dell, S. ;
Schmidt, S. D. ;
Corbett, K. S. ;
Swanson, P. A., II ;
Padilla, M. ;
Neuzil, K. M. ;
Bennett, H. ;
Leav, B. ;
Makowski, M. ;
Albert, J. ;
Cross, K. ;
Edara, V. V. ;
Floyd, K. ;
Suthar, M. S. ;
Martinez, D. R. ;
Baric, R. ;
Buchanan, W. ;
Luke, C. J. ;
Phadke, V. K. ;
Rostad, C. A. ;
Ledgerwood, J. E. ;
Graham, B. S. ;
Beigel, J. H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (25) :2427-2438
[9]   Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine [J].
Baden, Lindsey R. ;
El Sahly, Hana M. ;
Essink, Brandon ;
Kotloff, Karen ;
Frey, Sharon ;
Novak, Rick ;
Diemert, David ;
Spector, Stephen A. ;
Rouphael, Nadine ;
Creech, C. Buddy ;
McGettigan, John ;
Khetan, Shishir ;
Segall, Nathan ;
Solis, Joel ;
Brosz, Adam ;
Fierro, Carlos ;
Schwartz, Howard ;
Neuzil, Kathleen ;
Corey, Larry ;
Gilbert, Peter ;
Janes, Holly ;
Follmann, Dean ;
Marovich, Mary ;
Mascola, John ;
Polakowski, Laura ;
Ledgerwood, Julie ;
Graham, Barney S. ;
Bennett, Hamilton ;
Pajon, Rolando ;
Knightly, Conor ;
Leav, Brett ;
Deng, Weiping ;
Zhou, Honghong ;
Han, Shu ;
Ivarsson, Melanie ;
Miller, Jacqueline ;
Zaks, Tal .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) :403-416
[10]   Disruption of healthcare: Will the COVID pandemic worsen non-COVID outcomes and disease outbreaks? [J].
Barach, Paul ;
Fisher, Stacy D. ;
Adams, M. Jacob ;
Burstein, Gale R. ;
Brophy, Patrick D. ;
Kuo, Dennis Z. ;
Lipshultz, Steven E. .
PROGRESS IN PEDIATRIC CARDIOLOGY, 2020, 59